CharGer: clinical Characterization of Germline variants

Summary: CharGer (Characterization of Germline variants) is a software tool for interpreting and predicting clinical pathogenicity of germline variants. CharGer gathers evidence from databases and annotations, provided by local tools and files or via ReST APIs, and classifies variants according to ACMG guidelines for assessing variant pathogenicity. User‐designed pathogenicity criteria can be incorporated into CharGer's flexible framework, thereby allowing users to create a customized classification protocol. Availability and implementation: Source code is freely available at https://github.com/ding‐lab/CharGer and is distributed under the GNU GPL‐v3.0 license. Software is also distributed through the Python Package Index (PyPI) repository. CharGer is implemented in Python 2.7 and is supported on Unix‐based operating systems. Supplementary information: Supplementary data are available at Bioinformatics online.

[1]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[2]  Li Ding,et al.  Protein-structure-guided discovery of functional mutations across 19 cancer types , 2016, Nature Genetics.

[3]  Linda Jo Bone Jeng,et al.  An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants , 2016, Genetics in Medicine.

[4]  Xiaolei Zhang,et al.  ClinVar data parsing , 2017, Wellcome open research.

[5]  Emily H Turner,et al.  Actionable, pathogenic incidental findings in 1,000 participants' exomes. , 2013, American journal of human genetics.

[6]  Steven J. M. Jones,et al.  Pathogenic Germline Variants in 10,389 Adult Cancers. , 2018, Cell.

[7]  Quan Li,et al.  InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. , 2017, American journal of human genetics.

[8]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[9]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[10]  Keith Nykamp,et al.  Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria , 2017, Genetics in Medicine.

[11]  Li Ding,et al.  Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. , 2018, Cell systems.

[12]  K. Klooster,et al.  Germline Mutations in Predisposition Genes in Pediatric Cancer , 2016 .